138 related articles for article (PubMed ID: 9793077)
1. [Effects of tacrolimus ointment on type I (immediate and late) and IV (delayed) cutaneous allergic reactions in mice].
Sengoku T; Morita K; Sato S; Sakuma S; Ogawa T; Hiroi J; Fujii T; Goto T
Nihon Yakurigaku Zasshi; 1998 Sep; 112(3):221-32. PubMed ID: 9793077
[TBL] [Abstract][Full Text] [Related]
2. Possible inhibitory mechanism of FK506 (tacrolimus hydrate) ointment for atopic dermatitis based on animal models.
Sengoku T; Morita K; Sakuma S; Motoyama Y; Goto T
Eur J Pharmacol; 1999 Aug; 379(2-3):183-9. PubMed ID: 10497905
[TBL] [Abstract][Full Text] [Related]
3. [Pharmacological profile and clinical effect of tacrolimus ointment (Protopic ointment) for atopic dermatitis].
Hiroi J
Nihon Yakurigaku Zasshi; 2001 May; 117(5):351-7. PubMed ID: 11411345
[TBL] [Abstract][Full Text] [Related]
4. Effect of tacrolimus hydrate (FK506) ointment on spontaneous dermatitis in NC/Nga mice.
Hiroi J; Sengoku T; Morita K; Kishi S; Sato S; Ogawa T; Tsudzuki M; Matsuda H; Wada A; Esaki K
Jpn J Pharmacol; 1998 Feb; 76(2):175-83. PubMed ID: 9541280
[TBL] [Abstract][Full Text] [Related]
5. Wet-wrap treatment using dilutions of tacrolimus ointment and fluticasone propionate cream in human APOC1 (+/+) mice with atopic dermatitis.
Oranje AP; Verbeek R; Verzaal P; Haspels I; Prens E; Nagelkerken L
Br J Dermatol; 2009 Jan; 160(1):54-61. PubMed ID: 18795918
[TBL] [Abstract][Full Text] [Related]
6. Investigation on the effects of topical therapy with 0.1% tacrolimus ointment (Protopic) on intradermal skin test reactivity in atopic dogs.
Marsella R; Nicklin CF; Saglio S; Lopez J
Vet Dermatol; 2004 Aug; 15(4):218-24. PubMed ID: 15305928
[TBL] [Abstract][Full Text] [Related]
7. Topical glucocorticoid augments IgE-mediated passive cutaneous anaphylaxis in Balb/C mice and mast cell deficient WBB6F1 v/v mice.
Katayama I; Igawa K; Minatohara K; Nishioka K
Clin Exp Allergy; 1997 Dec; 27(12):1477-83. PubMed ID: 9433944
[TBL] [Abstract][Full Text] [Related]
8. Tacrolimus ointment for the treatment of atopic dermatitis: clinical and pharmacologic effects.
Rico MJ; Lawrence I
Allergy Asthma Proc; 2002; 23(3):191-7. PubMed ID: 12125507
[TBL] [Abstract][Full Text] [Related]
9. Effects of fujibitol, a remedy for nasal symptoms of immediate and delayed type allergic reactions.
Kakimoto M; Takasugi N; Fuwa T; Saito H; Sugimoto Y; Kamei C
Methods Find Exp Clin Pharmacol; 1999 Jun; 21(5):353-6. PubMed ID: 10420391
[TBL] [Abstract][Full Text] [Related]
10. [The antiinflammatory effect of budesonide ointment and cream].
Hiroi J; Fujii T; Satoh S; Yoneda K; Senoh H; Mori J; Kikuchi H
Nihon Yakurigaku Zasshi; 1985 Sep; 86(3):233-9. PubMed ID: 4085930
[TBL] [Abstract][Full Text] [Related]
11. Topically applied semaphorin 3A ointment inhibits scratching behavior and improves skin inflammation in NC/Nga mice with atopic dermatitis.
Negi O; Tominaga M; Tengara S; Kamo A; Taneda K; Suga Y; Ogawa H; Takamori K
J Dermatol Sci; 2012 Apr; 66(1):37-43. PubMed ID: 22381253
[TBL] [Abstract][Full Text] [Related]
12. [Effect of topical tacrolimus ointment on expression of Toll-like receptors 2 and 4 in lesional atopic dermatitis skin].
Xie ZQ; Liu LL; Yang GY; Zhu XJ
Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Aug; 38(4):420-3. PubMed ID: 16892151
[TBL] [Abstract][Full Text] [Related]
13. A multicentre, randomized, double-blind, controlled study of long-term treatment with 0.1% tacrolimus ointment in adults with moderate to severe atopic dermatitis.
Reitamo S; Ortonne JP; Sand C; Cambazard F; Bieber T; Fölster-Holst R; Vena G; Bos JD; Fabbri P; Groenhoej Larsen C;
Br J Dermatol; 2005 Jun; 152(6):1282-9. PubMed ID: 15948994
[TBL] [Abstract][Full Text] [Related]
14. Superiority of tacrolimus 0.1% ointment compared with fluticasone 0.005% in adults with moderate to severe atopic dermatitis of the face: results from a randomized, double-blind trial.
Doss N; Reitamo S; Dubertret L; Fekete GL; Kamoun MR; Lahfa M; Ortonne JP
Br J Dermatol; 2009 Aug; 161(2):427-34. PubMed ID: 19416227
[TBL] [Abstract][Full Text] [Related]
15. Tacrolimus nanoparticles based on chitosan combined with nicotinamide: enhancing percutaneous delivery and treatment efficacy for atopic dermatitis and reducing dose.
Yu K; Wang Y; Wan T; Zhai Y; Cao S; Ruan W; Wu C; Xu Y
Int J Nanomedicine; 2018; 13():129-142. PubMed ID: 29317821
[TBL] [Abstract][Full Text] [Related]
16. Tacrolimus ointment 0.03% is safe and effective for the treatment of mild to moderate atopic dermatitis in pediatric patients: results from a randomized, double-blind, vehicle-controlled study.
Schachner LA; Lamerson C; Sheehan MP; Boguniewicz M; Mosser J; Raimer S; Shull T; Jaracz E;
Pediatrics; 2005 Sep; 116(3):e334-42. PubMed ID: 16140675
[TBL] [Abstract][Full Text] [Related]
17. Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment.
Wollenberg A; Reitamo S; Girolomoni G; Lahfa M; Ruzicka T; Healy E; Giannetti A; Bieber T; Vyas J; Deleuran M;
Allergy; 2008 Jul; 63(7):742-50. PubMed ID: 18592619
[TBL] [Abstract][Full Text] [Related]
18. Quality Testing of Tacrolimus Ointment Mixed with Various Type of Ointments or Creams.
Nakane T; Doi H; Hirohara M; Hamashima H; Inoue Y
Biol Pharm Bull; 2018; 41(11):1632-1637. PubMed ID: 30381662
[TBL] [Abstract][Full Text] [Related]
19. Skin and systemic pharmacokinetics of tacrolimus following topical application of tacrolimus ointment in adults with moderate to severe atopic dermatitis.
Undre NA; Moloney FJ; Ahmadi S; Stevenson P; Murphy GM
Br J Dermatol; 2009 Mar; 160(3):665-9. PubMed ID: 19076975
[TBL] [Abstract][Full Text] [Related]
20. Tacrolimus ointment. A review of its therapeutic potential as a topical therapy in atopic dermatitis.
Cheer SM; Plosker GL
Am J Clin Dermatol; 2001; 2(6):389-406. PubMed ID: 11770393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
